Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
特应性皮炎中金黄色葡萄球菌皮肤定植增强食物过敏的机制
基本信息
- 批准号:10638821
- 负责人:
- 金额:$ 80.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-22 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAllergicAllergic ReactionAnaphylaxisAntibodiesAntigensAtopic DermatitisAttenuatedBacteriaBasophilsBindingCASP8 geneCaspaseCellsDataDendritic CellsDiseaseEpithelial CellsEpitheliumEventExposure toFoodFood HypersensitivityIL3 GeneIgEIn VitroInflammationInterleukin-4Intestinal AbsorptionIntestinal permeabilityMediatingMediatorMonoclonal AntibodiesMusMyosin Light Chain KinaseOralOvalbuminPathway interactionsPatientsPredispositionProteinsRoleSchemeSerumSignal TransductionSkinSkin colonizationStaphylococcal Enterotoxin BStaphylococcus aureusStromal CellsSuperantigensT-LymphocyteTNFRSF5 geneTechnical ExpertiseTestingTight JunctionsToxinabsorptionantigen challengedraining lymph nodefood antigenin vivoinhibitorintestinal barrierintestinal epitheliumkeratinocytemast cellmouse modelnovel therapeuticspassive sensitizationreceptorrecruitresponsesmall moleculesynergism
项目摘要
Abstract
The skin of AD patients is often colonized by S. aureus strains that produce superantigens (SAg), primarily
staphylococcal enterotoxin B (SEB). There is a positive association between S. aureus skin colonization and
food allergy in AD. The mechanism of this association is unknown. We have made the observation that
epicutaneous (EC) application of ovalbumin (OVA) and SAg producer S. aureus, or OVA and SEB, results in the
selective exaggeration of anaphylaxis to oral challenge with OVA compared to EC application of OVA alone.
Moreover, it results in exaggerated systemic anaphylaxis to oral challenge with BSA-TNP in mice passively
sensitized with IgE anti-TNP, indicating that the enhancement of food anaphylaxis was non-antigen-specific and
determined by factors beyond differences in IgE Ab levels or affinity. We propose to dissect the mechanisms of
SEB enhancement of IgE mediated oral anaphylaxis.
Preliminary data show that enhanced susceptibility to oral anaphylaxis in mice EC exposed to OVA+SEB
is associated with elevated levels of serum IL-4, dependent on IL-4 and IL-4R expression by intestinal epithelial
cells (IECs),and accompanied by increased intestinal permeability (IP). Enhanced susceptibility is inhibited by
Divertin, a small molecule that suppresses intestinal absorption of antigen via the paracellular pathway by
blocking the recruitment of myosin light chain kinase (MLCK) to the peri-junctional actinomyosin ring, where it
disrupts epithelial tight junctions. This suggests a critical role for MLCK in food allergy. In addition, the data show
that EC application of SEB causes a massive influx of basophils in skin-draining lymph nodes (dLNs) that was
dependent on CD40 keratinocyte (KC)-derived IL-33, and T cells. The recruited basophils enhanced the ability
of dendritic cells (DCs) from skin dLNs to drive Th2 polarization. Pretreatment of DCs in vitro with IL-4 also
promoted their capacity to drive Th2 polarization.
We propose to test the hypothesis that SEB from S. aureus that colonizes AD skin binds to CD40 on KCs
and triggers caspase 8 mediated cleavage and release of bioactive IL-33 which induces IL-3 release by T cells
leading to recruitment of basophils in dLNs. There, basophil-derived IL-4 promotes the Th2 polarizing ability of
DCs that have captured antigen encountered in the skin. These events drive a rise in systemic levels of Th2
derived IL-4. Increased IL-4 signaling in IECs synergizes with mediators released by MCs to promote MLCK
dependent barrier loss by causing redistribution of tight junction proteins. The resulting increased antigen
absorption triggers a forward amplification cycle of MC activation that exaggerates allergy to foods against which
the patient has been sensitized.
The studies proposed will define the mechanisms by which S. aureus skin colonization aggravates food
allergy and will uncover a central role of MLCK in this disease. They may lead to novel therapies for food allergy
that would target S. aureus skin colonization, CD40 in skin, IL-33 and MLCK.
抽象的
AD 患者的皮肤经常被产生超抗原 (SAg) 的金黄色葡萄球菌菌株定殖,主要是
金黄色葡萄球菌肠毒素 B (SEB) 与金黄色葡萄球菌皮肤定植呈正相关。
AD 中的食物过敏这种关联的机制尚不清楚。
卵清蛋白 (OVA) 和 SAg 生产者金黄色葡萄球菌或 OVA 和 SEB 的表皮 (EC) 应用会导致
与单独使用 OVA 的 EC 应用相比,OVA 口服刺激选择性夸大过敏反应。
此外,它会导致小鼠被动地对 BSA-TNP 口服刺激产生过度的全身过敏反应
用 IgE 抗 TNP 致敏,表明食物过敏反应的增强是非抗原特异性的,并且
由 IgE Ab 水平或亲和力差异以外的因素决定。我们建议剖析其机制。
SEB 增强 IgE 介导的口腔过敏反应。
初步数据显示,暴露于 OVA+SEB 的小鼠 EC 对口腔过敏反应的易感性增强
与血清 IL-4 水平升高相关,依赖于肠上皮的 IL-4 和 IL-4Rα 表达
细胞(IEC),并伴随着肠道通透性(IP)增强的敏感性受到抑制。
Divertin,一种小分子,通过细胞旁途径抑制肠道对抗原的吸收
阻断肌球蛋白轻链激酶 (MLCK) 向连接周围放线肌球蛋白环的募集,
此外,数据显示,MLCK 会破坏上皮紧密连接。
EC 应用 SEB 会导致嗜碱性粒细胞大量涌入皮肤引流淋巴结 (dLN),
依赖于 CD40 角质形成细胞 (KC) 衍生的 IL-33 和招募的嗜碱性粒细胞的 T 细胞增强了这种能力。
还用 IL-4 对皮肤 dLN 中的树突状细胞 (DC) 进行体外预处理以驱动 Th2 极化。
提高了它们驱动Th2极化的能力。
我们建议检验以下假设:来自定植 AD 皮肤的金黄色葡萄球菌的 SEB 与 KC 上的 CD40 结合
并触发 caspase 8 介导的生物活性 IL-33 的裂解和释放,从而诱导 T 细胞释放 IL-3
导致 dLN 中嗜碱性粒细胞的募集,其中嗜碱性粒细胞衍生的 IL-4 促进 Th2 极化能力。
捕获皮肤中遇到的抗原的 DC 会导致 Th2 的全身水平升高。
IEC 中IL-4 信号传导的增加与 MC 释放的介质协同作用,促进 MLCK
通过引起紧密连接蛋白的重新分布而导致的依赖性屏障丧失,从而导致抗原增加。
吸收会触发 MC 激活的前向放大循环,从而夸大对食物的过敏
病人已经过敏了。
拟议的研究将确定金黄色葡萄球菌皮肤定植加剧食物恶化的机制
过敏,并将揭示 MLCK 在这种疾病中的核心作用,它们可能会导致食物过敏的新疗法。
其目标是金黄色葡萄球菌皮肤定植、皮肤中的 CD40、IL-33 和 MLCK。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAIF SALIM GEHA其他文献
RAIF SALIM GEHA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAIF SALIM GEHA', 18)}}的其他基金
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10159668 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10265627 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
10589788 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Molecular and cellular mechanisms in food anaphylaxis
食物过敏反应的分子和细胞机制
- 批准号:
10030396 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
10381494 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
9974923 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Molecular and cellular mechanisms in food anaphylaxis
食物过敏反应的分子和细胞机制
- 批准号:
10408011 - 财政年份:2020
- 资助金额:
$ 80.01万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
9912718 - 财政年份:2018
- 资助金额:
$ 80.01万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10394995 - 财政年份:2018
- 资助金额:
$ 80.01万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10493663 - 财政年份:2018
- 资助金额:
$ 80.01万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
- 批准号:
10600767 - 财政年份:2023
- 资助金额:
$ 80.01万 - 项目类别:
Drug delivery platform for ocular allergy therapy
用于眼部过敏治疗的药物输送平台
- 批准号:
10484648 - 财政年份:2022
- 资助金额:
$ 80.01万 - 项目类别:
Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
- 批准号:
10503760 - 财政年份:2022
- 资助金额:
$ 80.01万 - 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10652657 - 财政年份:2022
- 资助金额:
$ 80.01万 - 项目类别: